Sort
8,912 grants matching “sars cov 2”
Genomics Core
$300,064Robert Sebra · Icahn School Of Medicine At Mount Sinai · U19 · FY2024 · AI
Genomics Core
$300,063Robert Sebra · Icahn School Of Medicine At Mount Sinai · U19 · FY2023 · AI
HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU) Administrative Supplement
$300,054Stephen A Spector · University Of California, San Diego · UM1 · FY2020 · AI
UCLA AIDS Prevention and Treatment Clinical Trials Unit
$300,001Judith S. Currier · University Of California Los Angeles · UM1 · FY2020 · AI
Double-Encapsulated mRNA Vaccine for COVID-19
$300,000Trevor P. Castor · Aphios Corporation · R43 · FY2023 · AI
Discovery of broad-spectrum, cross-neutralizing bispecific antibodies against SARS-CoV-2 using high throughput functional screening
$300,000George Guikai Wu · Amberstone Biosciences, Inc · R43 · FY2021 · AI
Gene Gun-delivered RNA vaccines.
$300,000Hannah Frizzell · Orlance, Inc. · R43 · FY2024 · AI
13/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center
$300,000Amber Reeves-Daniel · Wake Forest University Health Sciences · U01 · FY2024 · DK
Antibodies in the neurologic effects of COVID-19
$300,000Lena Al-Harthi · Rush University Medical Center · R56 · FY2024 · NS
EAGER: Assembling the Immunoglobulin Loci Across Mammalian Species and Across the Human Population
$300,000Pavel A Pevzner · University Of California-San Diego · · FY2020 · BIO
EAGER: Engineering Optical Nanobiosensors for Detection of Coronavirus Proteases
$300,000Stefan H Bossmann · Kansas State University · · FY2020 · ENG
Community-Engaged Covid-19 Interventions to Protect and Monitor Children
$300,000Ayman Al-Hendy · University Of Chicago · R01 · FY2021 · ES
SARS-CoV-2 vaccines based on RBDs with engineered glycosylation sites
$300,000Michael David Alpert · Emmune, Inc · R44 · FY2022 · AI
Double-Encapsulated mRNA Vaccine for COVID-19
$300,000Trevor P. Castor · Aphios Corporation · R43 · FY2024 · AI
SCH: Wearables for Health and Disease Knowledge (W4H)
$300,000Cyrus Shahabi · University Of Southern California · R01 · FY2023 · LM
A Novel Multi-Epitope-Based Universal Vaccine Against Multiple Coronavirus Variants of Concern
$300,000Hawa Vahed · Techimmune, Llc · R43 · FY2023 · AI
Targeting Covid-19 with a Therapeutic Interfering Particle
$300,000Raul Andino · Aleph Therapeutics, Inc. · R41 · FY2021 · AI
EAGER: Understanding the genomes and strain mutations of SARS-CoV-2 and other viruses using comparative and population genetic approaches
$300,000Jason Ernst · University Of California-Los Angeles · · FY2021 · BIO
Hazardous Materials Worker Health and Safety Training
$300,000Mitchel Rosen · Rbhs-School Of Public Health · U45 · FY2020 · ES
mTOR Regulation of Basal Antiviral Immunity in the Elderly
$300,000Joan Mannick · Tornado Therapeutics, Inc. · R01 · FY2022 · AG
IND-Enabling Development of a Small Molecule COVID Therapeutic
$300,000Ryan P Bennett · Oyagen, Inc. · R43 · FY2023 · AI
Alabama Clinical Trials Unit - Administrative Supplement: SARS-CoV-2 Testing
$300,000Edgar T Overton · University Of Alabama At Birmingham · UM1 · FY2020 · AI
Novel Peptide Fusion Inhibitors for the Treatment of COVID-19
$300,000Robert Tarran · Eldec Pharmaceuticals, Inc. · R41 · FY2022 · AI
Targeting galectin-3 to intervene COVID-19
$300,000Hafiz Ahmed · Glycomantra, Inc. · R43 · FY2022 · AI
EAGER: Portable device for rapid and label-free identification of COVID-19 using an ultra-miniature handheld Raman spectrometer
$300,000Mauricio Terrones · Pennsylvania State Univ University Park · · FY2020 · O/D